MA26624A1 - Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number: MA26624A1
Authority: MA; Morocco
Prior art keywords: preparation; new; pharmaceutical compositions; compositions containing; quinazolinamine
Prior art date: 1998-04-29

Application number

MA25557A

Other languages

English (en)

Inventor

Mysore Shanker Ravi

John Meldrum Allen Douglas

Norris Timothy

Paul Santafianos Dinos

William Raggon Jeffrey

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-29

Filing date

1999-04-28

Publication date

2004-12-20

1999-04-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-12-20 Publication of MA26624A1 publication Critical patent/MA26624A1/fr

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
CZAAKPFIWJXPQT-UHFFFAOYSA-N quinazolin-2-amine Chemical class C1=CC=CC2=NC(N)=NC=C21 CZAAKPFIWJXPQT-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

MA25557A 1998-04-29 1999-04-28 Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant MA26624A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8344198P	1998-04-29	1998-04-29

Publications (1)

Publication Number	Publication Date
MA26624A1 true MA26624A1 (fr)	2004-12-20

Family

ID=22178359

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25557A MA26624A1 (fr)	1998-04-29	1999-04-28	Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (41)

Country	Link
EP (1)	EP1076652B1 (fr)
JP (1)	JP4652569B2 (fr)
KR (1)	KR100668412B1 (fr)
CN (2)	CN101219999A (fr)
AP (1)	AP1252A (fr)
AR (1)	AR018201A1 (fr)
AT (1)	ATE295839T1 (fr)
AU (1)	AU759691C (fr)
BR (1)	BR9910025A (fr)
CA (1)	CA2330447C (fr)
CO (1)	CO5060467A1 (fr)
CZ (1)	CZ298230B6 (fr)
DE (1)	DE69925366T2 (fr)
DZ (1)	DZ2777A1 (fr)
EA (1)	EA002836B1 (fr)
EG (1)	EG24000A (fr)
ES (1)	ES2238825T3 (fr)
GT (1)	GT199900063A (fr)
HN (1)	HN1999000057A (fr)
HU (1)	HU227569B1 (fr)
ID (1)	ID27198A (fr)
IL (1)	IL139172A0 (fr)
MA (1)	MA26624A1 (fr)
ME (1)	MEP42008A (fr)
MX (1)	MXPA00010610A (fr)
MY (1)	MY136033A (fr)
NO (1)	NO317301B1 (fr)
NZ (1)	NZ508154A (fr)
OA (1)	OA11769A (fr)
PA (1)	PA8471001A1 (fr)
PE (1)	PE20000441A1 (fr)
PL (1)	PL196940B1 (fr)
RS (1)	RS50081B (fr)
SA (1)	SA99200216B1 (fr)
TN (1)	TNSN99079A1 (fr)
TR (1)	TR200003166T2 (fr)
TW (1)	TWI248437B (fr)
UA (1)	UA60363C2 (fr)
UY (1)	UY26099A1 (fr)
WO (1)	WO1999055683A1 (fr)
ZA (1)	ZA992972B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6706721B1 (en)	1998-04-29	2004-03-16	Osi Pharmaceuticals, Inc.	N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
YU13200A (sh)	1999-03-31	2002-10-18	Pfizer Products Inc.	Postupci i intermedijeri za dobijanje anti-kancernih jedinjenja
US7087613B2 (en)	1999-11-11	2006-08-08	Osi Pharmaceuticals, Inc.	Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA74803C2 (uk) *	1999-11-11	2006-02-15	Осі Фармасьютікалз, Інк.	Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
US7132427B2 (en)	2001-06-21	2006-11-07	Ariad Pharmaceuticals, Inc.	Quinazolines and uses thereof
US7078409B2 (en)	2002-03-28	2006-07-18	Beta Pharma, Inc.	Fused quinazoline derivatives useful as tyrosine kinase inhibitors
GB0223854D0 (en) *	2002-10-12	2002-11-20	Astrazeneca Ab	Therapeutic treatment
US7148231B2 (en) *	2003-02-17	2006-12-12	Hoffmann-La Roche Inc.	[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
WO2005049829A1 (fr)	2003-05-30	2005-06-02	Astrazeneca Uk Limited	Procede
DE602004009097T2 (de)	2003-06-10	2008-06-19	F. Hoffmann-La Roche Ag	1.3.4-triaza-phenalen- und 1,3,4,6-tetraazaphenalen-derivate
GB0403744D0 (en)	2004-02-20	2004-03-24	Astrazeneca Ab	Chemical process
CA2565721C (fr)	2004-05-06	2015-10-06	Bioresponse, L.L.C.	Preparations de diindolymethane destinee de traitement de leiomyomes
US7989486B2 (en)	2004-12-30	2011-08-02	Bioresponse, L.L.C.	Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions
EP2054393A1 (fr)	2006-07-28	2009-05-06	Synthon B.V.	Forme cristalline d'erlobtinib
WO2008057253A2 (fr)	2006-10-27	2008-05-15	Bioresponse, L.L.C.	Procédés antiparasitaires et compositions utilisant des indoles associés au diindolylméthane
KR101441930B1 (ko) *	2007-04-04	2014-09-19	시플라 리미티드	에르로티닙 및 그의 약학적으로 허용가능한 염의 제조방법
US8389531B2 (en)	2007-07-11	2013-03-05	Hetero Drugs Limited	Process for erlotinib hydrochloride
EP2218713A1 (fr)	2007-08-17	2010-08-18	Hetero Drugs Limited	Forme A du polymorphe de chlorhydrate d'erlotinibe sensiblement dépourvue de la forme B du polymorphe
KR101132937B1 (ko) *	2008-10-01	2012-04-06	주식회사종근당	Ｎ-(3-에티닐페닐)-6,7-비스(2-메톡시에톡시)-4-퀴나졸린아민 납실레이트 염
WO2010109443A1 (fr)	2009-03-26	2010-09-30	Ranbaxy Laboratories Limited	Procede de preparation d'erlotinib ou de ses sels pharmaceutiquement acceptables
WO2011068404A2 (fr)	2009-12-02	2011-06-09	Ultimorphix Technologies B.V.	Administration par inhalation de sel de mésylate de n-(3-éthynylphénylamino)-6,7-bis(2-méthoxyéthoxy)-4-quinazolinamine
DE202010006543U1 (de)	2010-05-07	2010-09-09	Ratiopharm Gmbh	Erlotinibresinat
HU230483B1 (hu)	2011-10-10	2016-07-28	Egis Gyógyszergyár Nyrt.	Erlotinib sók
US9593083B2 (en)	2012-09-04	2017-03-14	Shilpa Medicare Limited	Crystalline erlotinib hydrochloride process

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ243082A (en) *	1991-06-28	1995-02-24	Ici Plc	4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
JP2994165B2 (ja) *	1992-06-26	1999-12-27	ゼネカ・リミテッド	キナゾリン誘導体、その製造法および該キナゾリン誘導体を含有する抗癌作用を得るための医薬調剤
GB9323290D0 (en) *	1992-12-10	1994-01-05	Zeneca Ltd	Quinazoline derivatives
ATE446955T1 (de) *	1995-03-30	2009-11-15	Pfizer Prod Inc	Chinazolinone derivate
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines

1999
- 1999-04-08 NZ NZ508154A patent/NZ508154A/en not_active IP Right Cessation
- 1999-04-08 ES ES99909165T patent/ES2238825T3/es not_active Expired - Lifetime
- 1999-04-08 EA EA200001112A patent/EA002836B1/ru not_active IP Right Cessation
- 1999-04-08 CA CA002330447A patent/CA2330447C/fr not_active Expired - Lifetime
- 1999-04-08 RS YUP-661/00A patent/RS50081B/sr unknown
- 1999-04-08 EP EP99909165A patent/EP1076652B1/fr not_active Expired - Lifetime
- 1999-04-08 ME MEP-420/08A patent/MEP42008A/xx unknown
- 1999-04-08 HU HU0101818A patent/HU227569B1/hu unknown
- 1999-04-08 CN CNA2008100051101A patent/CN101219999A/zh active Pending
- 1999-04-08 OA OA1200000300A patent/OA11769A/en unknown
- 1999-04-08 ID IDW20002186A patent/ID27198A/id unknown
- 1999-04-08 AT AT99909165T patent/ATE295839T1/de not_active IP Right Cessation
- 1999-04-08 WO PCT/IB1999/000612 patent/WO1999055683A1/fr not_active Ceased
- 1999-04-08 MX MXPA00010610A patent/MXPA00010610A/es active IP Right Grant
- 1999-04-08 TR TR2000/03166T patent/TR200003166T2/xx unknown
- 1999-04-08 KR KR1020007011998A patent/KR100668412B1/ko not_active Expired - Lifetime
- 1999-04-08 IL IL13917299A patent/IL139172A0/xx not_active IP Right Cessation
- 1999-04-08 AU AU28509/99A patent/AU759691C/en not_active Expired
- 1999-04-08 CZ CZ20003974A patent/CZ298230B6/cs not_active IP Right Cessation
- 1999-04-08 BR BR9910025-8A patent/BR9910025A/pt not_active Application Discontinuation
- 1999-04-08 DE DE69925366T patent/DE69925366T2/de not_active Expired - Lifetime
- 1999-04-08 CN CN99805497A patent/CN1298396A/zh active Pending
- 1999-04-08 PL PL343766A patent/PL196940B1/pl not_active IP Right Cessation
- 1999-04-08 JP JP2000545843A patent/JP4652569B2/ja not_active Expired - Lifetime
- 1999-04-23 TW TW088106555A patent/TWI248437B/zh not_active IP Right Cessation
- 1999-04-26 HN HN1999000057A patent/HN1999000057A/es unknown
- 1999-04-27 PA PA19998471001A patent/PA8471001A1/es unknown
- 1999-04-27 AR ARP990101942A patent/AR018201A1/es active IP Right Grant
- 1999-04-27 MY MYPI99001636A patent/MY136033A/en unknown
- 1999-04-28 MA MA25557A patent/MA26624A1/fr unknown
- 1999-04-28 DZ DZ990077A patent/DZ2777A1/fr active
- 1999-04-28 TN TNTNSN99079A patent/TNSN99079A1/fr unknown
- 1999-04-28 ZA ZA9902972A patent/ZA992972B/xx unknown
- 1999-04-29 GT GT199900063A patent/GT199900063A/es unknown
- 1999-04-29 EG EG48299A patent/EG24000A/xx active
- 1999-04-29 PE PE1999000356A patent/PE20000441A1/es not_active Application Discontinuation
- 1999-04-29 AP APAP/P/1999/001523A patent/AP1252A/en active
- 1999-04-29 CO CO99026003A patent/CO5060467A1/es unknown
- 1999-06-02 SA SA99200216A patent/SA99200216B1/ar unknown
- 1999-08-04 UA UA2000116681A patent/UA60363C2/uk unknown
2000
- 2000-04-05 UY UY26099A patent/UY26099A1/es not_active Application Discontinuation
- 2000-10-27 NO NO20005453A patent/NO317301B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU2850999A (en)	1999-11-16
SA99200216B1 (ar)	2006-06-04
KR100668412B1 (ko)	2007-01-12
EG24000A (en)	2008-03-19
CA2330447C (fr)	2009-06-30
HN1999000057A (es)	1999-09-29
EP1076652A1 (fr)	2001-02-21
PA8471001A1 (es)	2000-09-29
OA11769A (en)	2005-07-25
GT199900063A (es)	2000-10-20
UA60363C2 (uk)	2003-10-15
CO5060467A1 (es)	2001-07-30
EA002836B1 (ru)	2002-10-31
TNSN99079A1 (fr)	2005-11-10
HU227569B1 (en)	2011-08-29
ES2238825T3 (es)	2005-09-01
JP2002513009A (ja)	2002-05-08
NO20005453L (no)	2000-12-20
AU759691C (en)	2004-04-29
DE69925366T2 (de)	2006-03-09
DZ2777A1 (fr)	2003-12-01
HUP0101818A1 (hu)	2002-03-28
CN101219999A (zh)	2008-07-16
ID27198A (id)	2001-03-08
NO317301B1 (no)	2004-10-04
DE69925366D1 (de)	2005-06-23
JP4652569B2 (ja)	2011-03-16
EP1076652B1 (fr)	2005-05-18
BR9910025A (pt)	2000-12-26
NZ508154A (en)	2003-07-25
EA200001112A1 (ru)	2001-04-23
NO20005453D0 (no)	2000-10-27
ATE295839T1 (de)	2005-06-15
MY136033A (en)	2008-07-31
AP1252A (en)	2004-02-25
PL343766A1 (en)	2001-09-10
TWI248437B (en)	2006-02-01
AR018201A1 (es)	2001-10-31
WO1999055683A1 (fr)	1999-11-04
HK1037180A1 (en)	2002-02-01
CZ20003974A3 (en)	2001-05-16
HUP0101818A3 (en)	2002-05-28
MEP42008A (en)	2011-02-10
PL196940B1 (pl)	2008-02-29
CZ298230B6 (cs)	2007-08-01
PE20000441A1 (es)	2000-05-23
CN1298396A (zh)	2001-06-06
AP9901523A0 (en)	1999-06-30
RS50081B (sr)	2009-01-22
KR20010078710A (ko)	2001-08-21
CA2330447A1 (fr)	1999-11-04
UY26099A1 (es)	2001-12-28
YU66100A (sh)	2003-07-07
IL139172A0 (en)	2001-11-25
MXPA00010610A (es)	2002-07-02
ZA992972B (en)	2000-10-30
AU759691B2 (en)	2003-04-17
TR200003166T2 (tr)	2001-02-21

Publication	Publication Date	Title
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26680A1 (fr)	2004-12-20	Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26424A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26712A1 (fr)	2004-12-20	Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26638A1 (fr)	2004-12-20	Derives d'isothiazole nouveaux, procede pour leur preparation et compoositions pharmaceutiques les contenant
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26740A1 (fr)	2004-12-20	Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26479A1 (fr)	2004-12-20	Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2794742B1 (fr)	2005-06-03	Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26558A1 (fr)	2004-12-20	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2816938B1 (fr)	2003-01-03	Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
MA26439A1 (fr)	2004-12-20	Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26505A1 (fr)	2004-12-20	Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2735777B1 (fr)	1997-09-12	Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.